iCAD and GE Healthcare unveil new AI tools to improve breast cancer detection at RSNA 2024.

iCAD, a leader in AI-powered cancer detection, is showcasing its FDA-cleared ProFound Detection Version 4.0 at the RSNA 2024 meeting and is partnering with Cascaid Health to launch ProFound Health, an AI-driven second-read service for mammograms in Q1 2025. GE Healthcare introduced the Pristina Via mammography system, designed to improve workflows and patient care with features like zero-click acquisition and vendor-neutral prior image comparison. Both innovations aim to enhance breast cancer screening accuracy and accessibility.

November 26, 2024
6 Articles

Further Reading